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Background/Aims  :  The  direct  toxic  effects  of  antibiotics  on  the  intestine  can  alter  digestive  functions  and  cause 
pathogenic bacterial overgrowth leading to antibiotic-associated diarrhea (AAD). Clostridium difficile (C. difficile) is widely 
known  to  be  responsible  for  10～20%  of  AAD  cases.  However,  Klebsiella  oxytoca,  Clostridium  perfringens, 
Staphylococcus  aureus,  and  Candida  species  might  also  contribute  to  AAD. 
Methods :  We  prospectively  analyzed  the  organisms  in  stool  and  colon  tissue  cultures  with  a  C.  difficile t o x i n  A  
a s s a y  i n  p a t i e n t s  w i t h  A A D  b e t w e e n  M a y  a n d  D e c e m b e r  2 0 0 5 .  I n  a d dition,  we  performed  the  C.  difficile t o x i n  A  
assays using an enzyme-linked fluorescent assay technique. Patients were enrolled who had diarrhea with more than 
three stools per day for at least 2 days after the initiation of antibiotic treatment for up to 6～8 weeks after antibiotic 
discontinuation. 
Results : Among 38 patients (mean age 59±18 years, M:F=18:20), the organism isolation rates were 28.9% (11/38) 
for stool culture, 18.4% (7/38) for colon tissue cultures and 13.2% (5/38) for the C. difficile toxin A assay. The overall 
rate of identification of organisms was 50.0% (19/38). Of the five  patients  that  had  a  positive  result  by  the  C. difficile 
toxin A assay, two had no organism isolated by the stool or colon tissue culture. The organisms isolated from the stool 
cultures were C. difficile (4), Klebsiella pneumoniae (K. pneumoniae) (3), Candida species (3), and Staphylococcus aureus 
(1).  C.  difficile  (4)  and  K.  pneumoniae  (3)  were  isolated  from  the  colon  tissue  culture. 
Conclusions  : F o r  C.  difficile  negative  AAD  patients,  K.  pneumoniae,  Candida  species,  and  Staphylococcus  aureus 
were  found  to  be  potential  causative  organisms.
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INTRODUCTION
Antibiotic-associated diarrhea (AAD) is defined as diarrhea that 
occurs in association with the administration of antibiotics
1). The 
direct  toxic  effects  of  antibiotics  on  the  intestine  can  alter 
digestive  functions  secondary  to  reduced  concentrations  of  the 
normal gut bacteria, or cause pathogenic bacterial overgrowth
2, 3). 
Understanding  the  different  mechanisms  that  cause  AAD  may 
help to prevent this condition, improve medical care and reduce 
medical cost. Clostridium difficile (C. difficile) is widely known to 
be responsible for approximately 10～20% of cases of AAD and 
almost  all  cases  of  pseudomembranous  colitis
4-7).  However, 
Klebsiella  oxytoca
8),  enterotoxin-producing  Clostridium  perfrin-
gens
9-11),  Staphylococcus  aureus
12),  Candida  species
13, 14), 
Salmonella  species,  and  Pseudomonas  aeruginosa
15) mi g h t  a l s o 
contribute  to  the  development  of  AAD
2, 5).
However,  little  is  known  about  other  candidate  organisms  in 
t h i s  c o n t e x t  a n d  t h e  c l i n i c a l  c o r r e l a t i o n  b e t w e e n  e n d o s c o p i cFigure 1. Three groups of antibiotic-associated diarrhea detected by endoscopy. Normal (A), non-specific colitis (B, C, D), and 
pseudomembranous  colitis  (E,  F). 
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Variables No.  (%)
Sex  (male  :  female)
Mean  age±SD  (range)  (years)
Underlying  disease
  D i a b e t e s  
    Cancer 
    Cerebrovascular  disease
    Chronic  renal  failure
  T r a u m a
    Chronic  liver  disease
    Chronic  obstructive  pulmonary  disease
    Congestive  heart  failure
    No  underlying  disease
Cause  of  antibiotic  uses
    Surgical  prophylaxis 
    Pneumonia 
  I n f e c t i o n  p r o p h y l a x i s  
    CAPD  peritonitis
  U r i n a r y  t r a c t  i n f e c t i o n  
  N e u t r o p e n i c  f e v e r  
    Sepsis 
    Cellulitis
    Cathter  associated  infection
    Unknown
18  :  20
59±18  (22-86)
Total  =38
  14  (36.8)
 9  ( 2 3 . 7 )
 9  ( 2 3 . 7 )
 8  ( 2 1 . 1 )
 6  ( 1 5 . 8 )
 4  ( 1 0 . 5 )
3  (7.9)
3  (7.9)
1  (2.6)
 9  ( 2 3 . 7 )
 8  ( 2 1 . 2 )
 6  ( 1 5 . 8 )
 4  ( 1 0 . 5 )
3  (7.9)
 4  ( 1 0 . 5 )
1  (2.6)
1  (2.6)
1  (2.6)
1  (2.6)
AAD,  antibiotic‐associated  diarrhea;  CAPD,  continous  ambula-
tory  peritoneal  dialysis;  SD,  standard  deviation
Table  1.  Demographic  characteristics  of  the  AAD  patients f i n d i n g s  a n d  t h e  o r g a n i s m s  i s o l a t e d  i n  p a t i e n t s  w i t h  A A D .  
Thus,  a  better  understanding  of  the  causes  of  AAD  is  needed. 
In  this  study,  we  prospectively  analyzed  the  organisms 
associated  with  AAD  using  stool  and  colon  tissue  cultures  in 
combination  with  the  C.  difficile  toxin  A  assay  in  patients  with 
AAD.  In  addition,  we  evaluated  the  clinical  correlation  between 
endoscopic  findings  and  the  organisms  isolated  from  stool  and 
colon  tissue  cultures.
MATERIALS AND METHODS
Patient  enrollment
Data on the stool and colon tissue cultures from 38 patients 
with  AAD  who  were  treated  at  the  Ewha  Womans  Mokdong 
Hospital  from  May  to  December  in  2005  were  collected 
prospectively.  In  addition,  we  tested  for  the  presence  of  C. 
difficile toxin A using the enzyme-linked fluorescent assay (ELFA) 
technique  (VIDAS
Ⓡ  C.  difficile T o x i n  A  I I ,  b i o Mérieux
ⓇSa,  Marcy 
I'Etoile,  France),  an  automated  test  for  the  qualitative  detection 
of  C.  difficile  toxin  A  in  stool  specimens.  The  relative  sensitivity 
and specificity of VIDAS
Ⓡ for C. difficile toxin A assay compared 
with  the  commercial  enzyme  immunoassay  are  87.6%,  and 
98.7%, respectively. We enrolled patients who had three or more 
stools  a  day  for  at  least  two  days  from  the  start  of  antibiotic 
administration  to  6～8  weeks  after  antibiotic  discontinuation. 
We excluded patients without a history of antibiotic use, those 
who discontinued using antibiotics 2 months before the diarrhea 
started,  and  those  with  a  diagnosis  of  acute  gastroenteritis, 
radiation  colitis,  inflammatory  bowel  disease,  ischemic  colitis,  or 
diarrhea due to a carcinoid tumor. The clinical characteristics of 
the patients with AAD were evaluated. Written informed consent 
was  obtained  from  each  patient  for  the  protocol,  which  was 
approved  by  the  ethics  committee  of  the  Ewha  Womans 
U n i v e r s i t y  M o k d o n g  H o s p i t a l .
Endoscopic  and  microbiologic  investigations
F o r  a l l  p a t i e n t s  w h o  s a t i s f i e d  t h e  a b o v e  c r i t e r i a ,  s t o o l  
specimens  and  colon  tissue  specimens  were  obtained  and 
cultured. The stool specimens were placed in transport medium 
(Amines
Ⓡ,  w/o  Charcol,  Asan  Pharmaceuticals  Co.  Ltd., 
Hwasung, Korea). Four tissue specimens from severely inflamed 
colon  mucosa  or  normal  mucosa  were  obtained  during 
endoscopy  using  sterile  biopsy  forceps.  The  tissue  specimens 
were collected into sterile eppendorf tubes (Safe lock test tube, 
Handok  Pharmaceuticals  Co.  Hwasung,  Korea). 
All  stool  and  tissue  specimens  were  cultured  in  selective 
medium containing cycloserine, cefoxitin and fructose in egg-yolk 
agar  (CCFA)  for  C.  difficile,  Brucella  medium  for  Clostridium 
perfringens,  blood  agar  plate  for  Staphlyococcus  aureus a n d  
Candida, MacConkey media for Klebsiella oxytoca and Klebsiella 
pneumoniae, a n d  Salmonella-Shigella  agar  for  Salmonella.  Insult 
kits (VITEK II
Ⓡ  GN, bioMérieux
Ⓡ  Sa, Marcy I'Etoile, France) were 
used to identify gram-negative species. The endoscopic findings 
associated with AAD were classified into three groups as follows: 
1) normal, no inflammation, 2) nonspecific colitis, which showed 
erythema,  edema  and  shallow  aphthous  ulcers,  and  3) 
pseudomembranous  colitis  (PMC)  with  whitish  exudates, 
hemorrhage  or  deep  ulcers  (Figure  1).
Statistical  analysis
Statistical analysis was performed using the Fisher's exact test 
and  the  linear-by-linear  association  in  SPSS  for  Windows  (Ver. 
11.0.1. 2001. Chicago, USA, SPSS Inc.). Throughout the study, 
p  values  less  than  0.05  were  considered  statistically  significant. 
RESULTS
D e m o g r a p h i c  c h a r a c t e r i s t i c s  o f  t h e  A A D  p a t i e n t s  
Thirty-eight  patients  who  were  treated  between  May  and 
December  2005  were  enrolled;  there  were  18  men  and  20 
women.  The  mean  age  was  59  (range,  22-86)  years.  Eight 
(21.1%) patients were evaluated by colonoscopy and 30 (78.9%) 
by  sigmoidoscopy.  All  but  one  patient  had  co-morbid  disease 
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Stool  culture
Total
Isolated  organism  No  organism
Tissue  culture
Isolated  organism  1  (2.6%)   6  (15.8%) 7  (18.4%)
No  organism 10  (26.3%) 21  (55.3%) 31  (81.6%)
Total 11  (28.9%) 27  (71.1%) 38  (100.0%)
p=0.648,  tested  by  Fisher’ s  exact  test
Table  2.  Comparison  of  isolated  organism  between  stool  and  colon  tissue  cultures
Organisms Tissue  culture  Stool  culture 
C.  difficile
 t o x i n  A  a s s a y  
Total
Clostridium  difficile 
Klebsiella  pneumoniae 
Candida  albicans 
Candida  tropicalis
Staphylococcus  aureus 
No  organism
  4  (10.5%)
3  (7.9%)
0  (0.0%)
0  (0.0%)
0  (0.0%)
31  (81.6%)
 4  ( 1 0 . 5 % )
3  (7.9%)
2  (5.3%)
1  (2.6%)
1  (2.6%)
27  (71.0%)
5  (13.2%)
-
-
-
-
33  (86.8%)
9  (23.7%)
6  (15.8%)
2  (5.3%)
1  (2.6%)
1  (2.6%)
19  (50.0%)
C.  difficile,  Clostridium  difficile
Table  3.  Isolated  organisms  according  to  tissue  and  stool  cultures  with  Clostridium  difficile t o x i n  A  a s s a y s 
Patients Sex/Age  Tissue  culture Stool  culture 
C.  difficile 
toxin  A  assay 
1 
2 
3 
4 
5 
6 
7 
8 
9 
M/80
M/66
M/80
F/46
F/71
M/73
M/71
M/57
F/76
+
-
-
+
+
+
-
-
-
+
-
-
-
-
-
+
+
+
+
+
+
-
+
-
+
-
-
C.  difficile,  Clostridium  difficile
Table  4.  Summary  of  Clostridium  difficile-positive  cases  by  tissue  cultures  and  stool  cultures  with  Clostridium  difficile t o x i n  A  a s s a y s 
0
10
20
30
40
50
60
Colonic tissue culture         Stool culture     C. difficile toxin assay   Both cultures+C. difficile toxin assay          
p =0.648
7 (18.4%)
11 (28.9%)
5 (13.2%)
p =0.008
19 (50.0%)
p<0.001
p= 0.046
(%) Culture positive
Figure  2.  A  comparison  of  positive  colon  tissue  cultures  and  stool 
c u l t u r e s  f o r  c a n d i d a t e  o r g a n i s m s  i n  p a t i e n t s  w i t h  a n t i b i o t i c -  a ssociated 
diarrhea The overall positive organism detection rate for both cultures in 
combination with C. difficile  toxin A  assay were significantly higher than 
colon tissue culture (p=0.008), stool culture (p<0.001) or C. difficile toxin
A  assay  (p=0.046). 
(9), chronic renal failure (8), trauma (6), chronic liver disease (4), 
chronic obstructive pulmonary disease (3), and congestive heart 
failure  (3).  The  reason  for  the  antibiotic  use  was  in  descending 
order:  surgical  prophylaxis  (9  cases),  pneumonia  (8),  infection 
prophylaxis  (6),  and  other  (Table  1).  The  most  commonly  used 
antibiotics  were  cephalosporins  (37.3%),  aminoglycosides 
(11.8%),  fluoroquinolone  (11.8%),  penicillin  derivatives  (6.4%), 
clindamycin  (2.7%),  and  others  (30.0%).  Two  (5.3%)  of  the  38 
patients had recurrent AAD. The mean duration of antibiotic use, 
in patients with AAD, was 14 days (range, 5-29). When used for 
surgical prophylaxis, the mean duration of antibiotic use was 15 
days  (range,  8-21).  In  such  cases,  the  antibiotics  were  usually 
used before surgery, then continued throughout the post-surgical 
period  during  the  hospital  stay.
Isolated  organisms
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Organisms
Endoscopic  findings
C.  difficile
K. 
pneumoniae
Other 
organism
No 
organism
Total
Normal 
Nonspecific  colitis 
PMC 
Total 
1  (2.6%)
3  (7.9%)
  5  (13.2%)
  9  (23.7%)
2  (5.3%)
2  (5.3%)
2  (5.3%)
 6  ( 1 5 . 8 % )
0  (0.0%)
2
*  (5.3%)
2
† ( 5 . 3 % )  
 4  ( 1 0 . 5 % )
3  (7.9%)
10  (26.3%)
  6  (15.8%)
19  (50.0%)
6  (15.8%)
17  (44.7%)
15  (39.5%)
38  (100.0%)
p=0.492, 
*;Staphylococcus  aureus  (1),  Candida  albicans  (1), 
†;Candidia  albicans  (1),  Candida  tropicalis  (1),  C.  difficile,  Clostridium  difficile;  K. 
pneumoniae,  Klebsiella  pneumoniae;  PMC,  pseudomembranous  colitis
Table  5.  Correlation  between  endoscopic  findings  and  isolated  organisms
(11/38)  from  the  stool  and  18.4%  (7/38)  from  colon  tissue 
(p=0.648) (Table 2). Organisms were identified in 50% (19/38) of 
the  patients  including  13.2%  (5/38)  positive  results  for  the  C. 
difficile  toxin  A  assay  (Table  3).  However,  no  organism  was 
isolated  by  stool  or  colon  tissue  culture  in  two  patients  out  of 
five with a positive C. difficile toxin A assay result (Table 4). The 
overall positive identification rate for organisms by both cultures 
in combination with the C. difficile toxin A assay was significantly 
higher than when any of the techniques were used alone, colon 
tissue culture (p=0.008), stool culture (p<0.001) or the C. difficile 
toxin  A  assay  (p=0.046)  (Figure  2).  From  the colon  tissues,  the 
organisms  identified  were  C.  difficile  (4  cases)  and  Klebsiella 
pneumoniae  (K.  pneumoniae)  (3).  From  the  stool  cultures,  the 
isolated  organisms  were  C.  difficile,  K.  pneumoniae,  Candida 
albicans,  Candida  tropicalis,  and  Staphylococcus  aureus ( T a b l e  
3).  Overall,  C.  difficile  accounted  for  23.7%  (9/38)  of  the  AAD 
patients  and  K.  pneumoniae f o r  1 5 . 8 %  ( 6 / 3 8 ) .  
Clinical  correlation  between  endoscopic  findings  and  isolated 
organisms
The endoscopic findings associated with AAD were classified 
into  three  groups:  1)  normal  in  six  patients  (15.8%),  2) 
nonspecific  colitis  in  17  patients  (44.7%),  which  showed 
erythema,  edema  and  shallow  aphthous  ulcers,  and  3)  PMC  in 
15 patients (39.5%). The isolated organisms can be categorized 
into  four  groups:  1)  C.  difficile, 2 )  K.  pneumoniae,  3)  other 
organisms  such  as  Candidia  albicans,  Candida  tropicalis,  and 
Staphylococcus  aureus,  and  4)  no  organism.  There  was  no 
clinical  correlation  between  the  endoscopic  findings  and  the 
organisms  isolated  (p=0.492)  (Table  5).
DISCUSSION
The  majority  of  cases  with  AAD  are  caused  directly  or 
i n d i r e c t l y  b y  a l t e r a t i o n s  o f  t h e  g u t  m i c r o f l o r a  d u e  t o  t h e  
antibiotics  ingested.  Changes  in  the  gut  flora  ecosystem  allow 
pathogens  to  proliferate.  Using  conventional  anaerobic  culture 
techniques,  Bacteroides,  Eubacterium,  Clostridium,  Ruminoc-
occus,  Peptococcus,  Peptostreptococcus,  Bifidobacterium,  and 
Fusobacterium were found to represent the predominant genera 
of  t he st ool  f l ora
2). However , cul t ure- based met hods provi de an 
incomplete picture of the various microbial populations of the gut 
because  many  bacteria  are  difficult  to  culture.  Multiple 
laboratories have reported that only 10～20% of stool specimens 
are positive with C. difficile toxin testing
4-7).
  This cytotoxin assay, 
for toxin B based on tissue culture, is the gold standard for the 
diagnosis of C. difficile and still considered as the most sensitive 
test available for clinical testing
16).
  In our study, however, the C. 
difficile t o x i n  A  a s s a y  w a s  n e i t h e r  s u p e r i o r  t o  t h e  C.  difficile 
a n a e r o b i c  s t o o l  c u l t u r e  n o r  t h e  t i s s u e  c u l t u r e .  T h i s  r e s u l t  i s  
attributed to the fact that the methods used were based on the 
ELFA technique. C. difficile was found to be the most common 
pathogen  in  our  study,  and  accounted  for  23.7%  (9/38)  of  all 
AAD  cases. 
Overall,  organisms  were  identified  in  50%  (19/38)  of  the 
patients  by  stool  and  tissue  cultures  including  the  C.  difficile 
toxin A assay. The organisms were isolated at a rate of 28.9% 
(11/38) from the stool culture and 18.4% (7/38) from the colon 
tissue culture (p=0.648). Only one patient had a positive result in 
both  the  stool  and  colon  tissue  cultures.  There  was  no 
significant difference between the stool specimens and the colon 
tissue  specimens  with  respect  to  the  rate  of  positive  cultures. 
However, there was a significant difference in the culture results 
i n  t h e  c o m p a r i s o n s  b e t w e e n  s t o o l  s p e c i m e n s  a n d  c o l o n  t i s s u e  
specimens.  This  may  be  associated  with  the  difference  in  the 
time interval between the onset of diarrhea and the microbiology 
examination  of  the  two  types  of  specimens.  In  addition,  our 
results  suggest  that  stool  specimens  are  more  likely  to  contain 
these organisms than are colon tissue specimens, although our 
results  did  not  reach  statistical  significance  (p=0.648).  Recently, 
some  reports  have  suggested  that  cultures  of  colon  biopsy 
tissue,  obtained  during  a  colonoscopy,  are  more  frequently 
positive than are stool cultures for some patients with presumed 
acute  infectious  colitis;
17, 18)  therefore,  this  finding  is 
controversial
19, 20). 
C.  difficile  isolates  can  be  either  toxigenic  or  nontoxigenic. 
Toxigenic  strains  of  C.  difficile  produce  an  enterotoxin  (toxin  A) 
a s  w e l l  a s  c y t o t o x i n  ( t o x i n  B ) .  T h e  t o x i n  A  m a y  b e  a  b e t t e r  The  Korean  Journal  of  Internal  Medicine  :  Vol.  23,  No.  1,  March  2008 14
marker for the presence of C. difficile, because it is more stable 
than toxin B. Non-toxigenic strains have not been linked with C. 
difficile-related  disease
21).
  Since  many  healthy  infants,  children 
and adults may be carriers of C. difficile, stool cultures may yield 
misleading  or  “false-positive”  results  in  patients  with  simple 
AAD  because  of  coincidental  intestinal  carriage  of  the 
organism
22).
  Although the culture methods have a high sensitivity, 
the  potential  problem  with  the  culture  is  the  delay  of  48-72 
hours  for  the  results,  and  more  importantly,  the  lack  of 
specificity
23).  In  this  context  (Table  4),  four  patients  with  culture 
positive C. difficile and a negative toxin A assay might have had 
a  non  C.  difficile-associated  diarrhea  or  a  C.  difficile t o x i n  
B-associated disease. Therefore, stool and colon tissue cultures 
and the C. difficile toxin A assay based on ELFA are considered 
useful  complementary  tools  for  identifying  the  causative 
pathogens  in  patients  with  AAD.
Other enteric organisms that can cause AAD include Klebsiella 
oxytoca
8),  enterotoxin-producing  Clostridium  perfringens
9-11), 
Staphylococcus  aureus
12),  Candida  species
13, 14),  Salmonella 
species,  and  Pseudomonas  aeruginosa
15).  I n  o u r  s t u d y ,  K. 
pneumoniae (15.8%), Candida albicans (5.2%), Candida tropicalis 
(2.6%), and Staphylococcus aureus (2.6%) were isolated. We did 
not stratify patients by the treatment of K. pneumoniae, Candida 
species  and  S.  aureus.  We  simply  discontinued  the  antibiotics 
that were thought to cause the AAD and started treatment with 
metronidazole  or  vancomycin,  well  known  treatment  for  AAD, 
regardless  of  the  candidate  organisms.  In  cases  with  K. 
pneumoniae,  all  six  patients  were  completely  improved  whether 
they  were  treated  with  oral  metronidazole  (4  cases)  or  had  no 
antibiotic  treatment  (2  cases). 
Although  Klebsiella  oxytoca  was  isolated  from  stools  and 
colon  biopsy  specimens  of  patients  with  C.  difficile  negative 
antibiotic-associated  hemorrhagic  colitis
8),  i n  o u r  s t u d y ,  K. 
pneumoniae was the second most common organism. Klebsiella 
is  a  ubiquitous  gram-negative  enterobacterium  that  causes 
community-acquired  pneumonia  and  nosocomial  infections
24).
 
Previous  antibiotic  therapy  is  significantly  associated  with  the 
acquisition  of  Klebsiella
25).
  In  addition,  K.  pneumoniae,  a 
commensal  organism  of  the  human  gastrointestinal  tract,  has 
been  reported  occasionally  to  be  a  cause  of  diarrhea  in 
humans
26).  Moreover,  the  enterotoxigenicity  of  K.  pneumoniae 
has been reported to be a cause of childhood gastroenteritis
27, 28).
 
Although the exact mechanism by which K. pneumoniae causes 
diarrhea is not known, K. pneumoniae may be a potential cause 
of  AAD. 
I n  t h e  p r e s e n t  s t u d y ,  t h e  e n d o s c o p i c  f i n d i n g s  w e r e  n o t  
specific  for  C.  difficile  infection  and  no  diagnosis  was  made  by 
endoscopic  findings  alone.  The  role  of  endoscopy  for  the 
diagnosis of C. difficile colitis has been reported to be secondary 
in  the  workup  of  AAD,  since  endoscopy  is  costly  and  the 
f i n d i n g s  n o t  s e n s i t i v e ;  w h e r e a s  n o n i n v a s i v e  s t o o l  t e s t s  a r e  
inexpensive  and  accurate
29).  However,  endoscopic  studies  can 
eliminate  other  causes  of  diarrhea  such  as  inflammatory  bowel 
disease and ischemic colitis, and they allow biopsy of suspicious 
lesions  as  well  as  demonstrate  the  severity  of  the  AAD. 
This  study  is  the  first  to  investigate  the  clinical  correlations 
between endoscopic findings and isolated organisms associated 
with  AAD.  The  use  of  a  selective  medium  for  the  stool  and 
biopsy specimen cultures is necessary to demonstrate accurately 
the  presence  or  absence  of  organisms.  However,  the 
cost-effectiveness  of  this  method  requires  confirmation.  The 
present study had several limitations. First, the sample size was 
small; a larger study is required to confirm our results. Second, 
a causal relationship between the presence of organisms in the 
stool and diarrhea is difficult to establish. In the context of AAD, 
the  question  as  to  whether  such  ‘opportunistic’  agents  are 
innocent bystanders or true pathogens responsible for diarrhea is 
crucial.  With  the  exception  of  C.  difficile,  evidence  for  other 
heterogeneous  organisms  such  as  Clostridium  perfringens, 
Staphylococcus  aureus a n d  Candida  species  was  low  to 
intermediate
2).
  W h e n  a  d i a g n o s i s  o f  A A D  i s  m a d e  i n  a  p a t i e n t  
with negative tests for C. difficile and/or its toxins, these isolated 
organisms  might  be  considered  as  possible  pathogenic 
causes
22).  However,  it  is  uncertain  whether  these  species  were 
colonized  organisms  or  pathogens,  because  this  study  did  not 
h a v e  a  ma t c h e d  c o n t r o l  g r o u p  f o r  c o m p a r i s o n .  
In conclusion, C. difficile was found to be the most common 
pathogen in patients with AAD in the present study. In C. difficile 
negative  AAD  patients,  K.  pneumoniae,  Candida  albicans, 
Candida tropicalis, Staphylococcus aureus, or other conventional 
enteric  pathogens  might  be  considered  as  possible  causative 
organisms.  Interestingly,  K.  pneumoniae w a s  f o u n d  t o  b e  t h e  
second  most  common  organism  found  in  patients  with  AAD. 
Further  investigations  are  needed  to  evaluate  the  possible 
etiologic  role  of  K.  pneumoniae  in  AAD.
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